Paclitaxel Injection Market Is Projected to Extend at a 4560 Million USD by the End of 2025, with a CAGR of 11.1%: QY Research
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
View full press release